Clinically led, evidence based, AI powered

Our Company

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L) and is based in the Schrödinger Building, located on Oxford Science Park.

Our People

Sensyne Health’s proven team has built multiple £500m+ health & technology businesses over the past 15 years including IPO, M&A experience in regulated healthcare and digital technologies, and is complemented by a multi-disciplinary team combining AI expertise with deep clinical experience.

View people

Insights

Opinion Leaders and Subject Matter Experts in the fields of digital healthcare, clinical AI and life sciences research share their views on current issues and developments in their fields.

View Insights

Schrödinger Building, Oxford Science Park

Oxford Office

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

+44 (0) 330 058 1845

Contact us

For press enquiries, please contact press@sensynehealth.com